Study Finds Cannabidiol May Reduce Alzheimer’s Brain Inflammation | AI News Digest
Recent findings published in eNeuro suggest that cannabidiol (CBD), a nonpsychoactive component of cannabis, may help reduce brain inflammation associated with Alzheimer's disease. Researchers at Augusta University conducted a study using a mouse model, which revealed that daily inhalation of CBD led to a decrease in inflammatory markers and enhancements in memory-related behaviors. This research shifts the emphasis from the well-known amyloid plaques and tau tangles to the impact of immune dysfunction on the progression of Alzheimer's. The results hint at the potential for CBD to influence immune pathways, opening the door to a new treatment strategy for the disease. Although the study is still in the preclinical phase, it provides a foundation for upcoming clinical trials to assess the effectiveness of CBD in treating human patients with Alzheimer's and similar disorders.
Read more...
